🇺🇸 FDA
Patent

US 11534397

Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof

granted A61KA61K31/382A61K9/0075

Quick answer

US patent 11534397 (Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/382, A61K9/0075, A61K9/1623, A61K9/5015